Diffuse large B-cell lymphoma is an aggressive blood cancer treated with an antibody plus four chemotherapy drugs. This approach cures many patients but fails in about three in ten, and the chemotherapy can cause heart damage, a particular concern for older people. Because clinicians cannot reliably predict who will respond, they often avoid newer, potentially less toxic regimens.
A new study in pet dogs offers a way to predict response early. Researchers from Cummings School of Veterinary Medicine at Tufts University and UMass Chan analysed blood samples from a prior clinical trial. Dogs were randomly assigned to one of three regimens. Each combined a canine antibody equivalent to the human drug with a low dose of doxorubicin, followed by one of three experimental immune‑boosting therapies; two of these are also being tested in humans.
Rather than tumour tissue, the team measured gene activity in circulating immune cells before treatment, seven days into treatment (just before the novel immunotherapy), at the end of the chemo‑immunotherapy cycle, and at relapse or 400 days for dogs that remained cancer‑free. They compared patterns between dogs that relapsed quickly and those that survived much longer.
The study, published in Scientific Reports, found that higher activity of CD1E and CCL14 was linked to long‑term survival; CD1E helps T cells recognise cancer and CCL14 recruits immune cells. By contrast, interferon‑stimulated genes were associated with worse outcomes and earlier relapse. Heather Gardner developed a simple lab test to detect the early‑warning genes, and Cheryl London plans to test whether using such a test to guide treatment can improve survival. The researchers say these results point toward blood tests that could guide more personalised decisions in veterinary and human lymphoma care.
Difficult words
- chemotherapy — treatment using drugs to kill cancer cells
- antibody — protein made by immune system to fight infection
- immune — related to the body's infection defence system
- circulate — move through the body or through bloodcirculating
- gene activity — how active genes are in making molecules
- predict — say what will happen before it occurs
- personalised — made or chosen for a single person
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Do you think a blood test is better than a tumour biopsy to guide treatment? Why or why not?
- How could a test that predicts response early help older patients who worry about heart damage from chemotherapy?
- What are the benefits and limitations of using studies in pet dogs to improve human cancer care?
Related articles
Untreated Sleep Apnea Speeds Heart Aging and Raises Death Risk
A laboratory study using a long-term mouse model finds that untreated obstructive sleep apnea — recreated by repeated drops in oxygen during sleep — leads to faster cardiovascular aging and higher mortality. Researchers call for early screening and treatment.
Wearable 10‑Minute Antibody Sensors from University of Pittsburgh
Researchers at the University of Pittsburgh made a wearable biosensor that detects antibodies in interstitial fluid in 10 minutes without a blood draw. The tiny carbon nanotube sensors are highly sensitive and the work appears in Analytical Chemistry.
Hantavirus linked to international cruise ship
WHO reports 11 hantavirus cases, including three deaths, connected to the Dutch-flagged MV Hondius that sailed from Argentina to Cape Verde. Some passengers later travelled through South Africa; health authorities say public risk remains low.
African leaders call for local funding of medical innovation
A group of African science leaders says Africa must develop and pay for its own medical innovations to improve health and rely less on uncertain international funding. They call for more national investment, reforms and stronger research systems.